|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 116.65 USD | +1.36% |
|
-1.58% | +18.10% |
| 07-15 | BofA Securities Raises Incyte Price Target to $136 From $124 | MT |
| 07-14 | Barclays Adjusts Incyte Price Target to $134 From $117, Maintains Overweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INCYTE CORPORATION | Biopharmaceuticals | +1.36% | -1.58% | +18.10% | +68.50% | +48.92% | 22.99B |  | | |
- Stock Market
- Stocks
- INCY Stock
- Charts Incyte Corporation
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
